We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Market indexes slogged forward most of the morning this Tuesday, finally looking to have gained some traction after the noon hour aheads of what was supposed to be renewed talks between House Speaker Nancy Pelosi and Treasury Secretary Steve Mnuchin this afternoon. Then, a Tweet from a presumably resting President Trump as he continues his recovery from his Covid-19 infection pulled the plug on the enterprise: “I have instructed my representatives to stop negotiating until after the election…” Markets took the cue and plummeted into the red.
The Nasdaq fell furthest, -1.57% or -177.88 points; the S&P 500 -1.40%, -47.68 points, was next; the Dow was close behind, -1.34% or -375.80 points; and the Russell 2000 outperformed the field again, -0.3% or -4.67%. President Trump has indicated that he’ll be ushering in a “major” new Stimulus Package sometime after the election. As recently as this morning, Fed Chair Jerome Powell was openly clamoring for new congressional relief now, saying that even if the amounts allotted are more than necessary, they will not go to waste. “Too little support would lead to a weak recovery,” the Fed Chair said.
Ten of the 11 major sectors finished the day lower, including Consumer Discretionary, which dropped by more than 2%. Airline stocks were down — American (AAL - Free Report) was -4.5% on the day — while Amazon (AMZN - Free Report) fell 3% on the day. Only Utilities managed to close higher, on seasonal colder weather conditions which will bolster usage of natural gas heating through the winter months.
Levi Strauss & Co. (LEVI - Free Report) is up more than 10% in late trading today on its Q3 earnings report after the closing bell. A loss of 8 cents per share on the bottom line was more than 3x better than the -27 cents in the Zacks consensus. Revenues of $1.06 billion also posted a major positive surprise above the $766.84 million expected. Digital Sales rose 52% year over year, with Women’s apparel up to 37% on total revenues (50% remains the company’s goal). LEVI has not missed on earnings since its IPO in early 2019, with a trailing 4-quater average beat of more than 10%. For more on LEVI’s earnings, click here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Markets Tumble on "No Relief Package" Tweet
Market indexes slogged forward most of the morning this Tuesday, finally looking to have gained some traction after the noon hour aheads of what was supposed to be renewed talks between House Speaker Nancy Pelosi and Treasury Secretary Steve Mnuchin this afternoon. Then, a Tweet from a presumably resting President Trump as he continues his recovery from his Covid-19 infection pulled the plug on the enterprise: “I have instructed my representatives to stop negotiating until after the election…” Markets took the cue and plummeted into the red.
The Nasdaq fell furthest, -1.57% or -177.88 points; the S&P 500 -1.40%, -47.68 points, was next; the Dow was close behind, -1.34% or -375.80 points; and the Russell 2000 outperformed the field again, -0.3% or -4.67%. President Trump has indicated that he’ll be ushering in a “major” new Stimulus Package sometime after the election. As recently as this morning, Fed Chair Jerome Powell was openly clamoring for new congressional relief now, saying that even if the amounts allotted are more than necessary, they will not go to waste. “Too little support would lead to a weak recovery,” the Fed Chair said.
Ten of the 11 major sectors finished the day lower, including Consumer Discretionary, which dropped by more than 2%. Airline stocks were down — American (AAL - Free Report) was -4.5% on the day — while Amazon (AMZN - Free Report) fell 3% on the day. Only Utilities managed to close higher, on seasonal colder weather conditions which will bolster usage of natural gas heating through the winter months.
Levi Strauss & Co. (LEVI - Free Report) is up more than 10% in late trading today on its Q3 earnings report after the closing bell. A loss of 8 cents per share on the bottom line was more than 3x better than the -27 cents in the Zacks consensus. Revenues of $1.06 billion also posted a major positive surprise above the $766.84 million expected. Digital Sales rose 52% year over year, with Women’s apparel up to 37% on total revenues (50% remains the company’s goal). LEVI has not missed on earnings since its IPO in early 2019, with a trailing 4-quater average beat of more than 10%. For more on LEVI’s earnings, click here.
Questions or comments about this article and/or its author? Click here>>
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>